Clinical Trial

A Clinical Study to Evaluate the Efficacy in Improving Dark Spots After 8 Weeks of Use of Facial Sunscreens in Adult Participants

Study acronym: El Porto Ex-US
Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the efficacy of a facial sunscreen under two experimental conditions-untinted and tinted-in improving facial spots (melasma and solar lentigines/post-inflammatory hyperpigmentation) after 8 weeks of product use under normal conditions by adult participants.
Trial Details
NCT Number NCT07679945
Lead Sponsor Kenvue Brands LLC
Conditions Post-inflammatory Hyperpigmentation, Melasma, Solar Lentigo
Enrollment 152 participants
Start Date 2026-06-02
Primary Completion 2026-09-25 (estimated)
Study Completion 2026-09-25 (estimated)
Updated on ClinicalTrials.gov 2026-07-01